Glycomic Characterization Service
At CD BioGlyco, we leverage over specialized expertise in glycobiology to offer a comprehensive glycomic characterization service. Our service is meticulously designed to elucidate the precise structures and profiles of glycans present in various biological samples, providing researchers and pharmaceutical developers with critical insights into glycan function, biomarker identification, and drug development.
Overview
Carbohydrates are involved in most biological processes in cells, and any alterations in glycan structure or composition may be a cause or consequential attribute of biochemical imbalance. Therefore in current glycobiology research, it is increasingly significant to understand the structural details of biologically important polysaccharides. During the past years, sophisticated mass spectrometry techniques and instrumentation have been developed rapidly in the biomedical field. While these developments have been driven primarily by the demand in the fields of protein science and proteomic research, contemporary glycobiology has also benefited from these developments.
Characterization of the glycome is a key part of understanding the biological basis of health and disease. A number of technologies and methods have been developed to help decipher glycosylation and elucidate glycomic changes. At present, novel mass analyzers and tandem mass spectrometry techniques are now being used to determine the sequence, linkage, chain branching, and other aspects of oligosaccharide structures with unprecedented sensitivity and mass resolution.
Key Technologies
We employ high-performance liquid chromatography (HPLC) for efficient separation of glycan species, often coupled with fluorescence detection for enhanced sensitivity. Mass spectrometry (MS), including techniques like Matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS), electrospray ionization tandem-MS (ESI-MS/MS), and LC-MS/MS, is central to our approach, enabling precise mass determination, structural elucidation, and quantitative profiling of glycans.
Comprehensive Glycomic Characterization Service: Unlocking Biological Insights
CD BioGlyco has made significant progress in the development of powerful structural tools to probe even the most complex structural properties of various intracellular and intercellular signaling and regulation. We offer a wide range of services to our clients in the field of glycomics, including glycan profiling, glycan sequencing, and glycan structure analysis.
Our glycomic characterization service follows a meticulously designed, multi-stage workflow to ensure accurate, reproducible, and comprehensive analysis of glycans from diverse biological samples. Our service process is as follows:
- Sample Preparation
Specific protein denaturation, lipid removal, and nucleic acid extraction protocols are employed to ensure optimal glycan accessibility and purity.
- Glycan Release and Derivatization
N-glycans are enzymatically released using PNGase F, and O-glycans are released using reductive β-elimination or non-reducing chemical methods. Derivatization or permethylation with fluorescent markers is then performed to enhance detection sensitivity.
- Glycan Separation and Detection
High-performance liquid chromatography (HPLC) is used to separate complex glycan mixtures, while liquid chromatography-mass spectrometry (LC-MS) is used to isolate and detect individual glycan species.
- Structural Elucidation via MS
Matrix-assisted laser desorption ionization time-of-flight MS (MALDI-TOF-MS) is used to precisely measure glycan masses, and tandem MS (MS/MS) analyzes monosaccharide composition, linkage types, and branching patterns.
- Data Analysis and Report
We utilize specialized software and databases to interpret and validate glycan profiles and structures and provide a comprehensive report detailing the experimental procedures, raw data, and processed results.
Workflow
Publication Data
Journal: Molecules
IF: 4.6
Published: 2022
Results: This article focuses on the development and application of an innovative analytical platform. This platform combines MS with glycomics and glycoproteomics approaches. This study aims to utilize an advanced integrated system to functionally characterize the glycosylation inhibitor pictilisib, encompassing glycomics analysis, proteomics analysis, and in vitro experiments. This study highlights the application of MS in identifying potential glycosylation inhibitors and evaluating their effects on cell surface glycoprotein abundance and protein interactions.
Applications
- Glycomic characterization services are used in immunology and vaccine development to elucidate the role of glycans in immune recognition and host-pathogen interactions.
- Glycomic characterization services can be used to investigate altered glycosylation patterns in cancer cells to assess tumor progression, metastasis, and drug resistance.
- Glycomic characterization services can be used to explore the role of glycans in neural development, synaptic plasticity, and neurodegenerative diseases.
- Glycomic characterization services can be used to analyze glycans in food for nutritional assessment, allergenicity studies, and the development of functional foods.
Advantages
- Our team of highly skilled scientists brings extensive experience in handling diverse sample types and tackling challenging glycomic questions, ensuring reliable and insightful results.
- We have high-resolution MS and advanced chromatographic systems. This enables us to achieve superior sensitivity, accuracy, and comprehensive coverage in glycan detection and structural elucidation.
- Our service encompasses a broad spectrum of glycan analysis, from detailed N- and O-glycan profiling to precise glycan sequencing and complex structural analysis, including isoform and spatial organization studies. This holistic approach ensures that all aspects of your glycomic characterization needs are met.
Frequently Asked Questions
CD BioGlyco is your trusted partner in glycobiology, offering a comprehensive glycomic characterization service that provides unparalleled insights into the intricate world of glycans. From precise profiling and sequencing to detailed structural elucidation, our advanced technological platforms and expert scientific team are dedicated to supporting your research and development endeavors across diverse applications. Please feel free to contact us to discuss your specific project needs.
Associated Services
To further support your research and development goals, CD BioGlyco offers a suite of complementary services and specialized options related to glycomics:
- Glycoprotein Analysis: Beyond glycan characterization, we offer comprehensive analysis of intact glycoproteins, including glycosylation site mapping and occupancy determination.
- Glycan Array Services: Utilize our high-throughput glycan array platforms for rapid screening of glycan-binding interactions, essential for drug discovery and immunology studies.
- Carbohydrate Vaccine Development: Leverage our expertise in designing and characterizing glycoconjugate vaccines for infectious disease prevention.
Reference
- Alvarez, M.R.S.; et al. An integrated mass spectrometry-based glycomics-driven glycoproteomics analytical platform to functionally characterize glycosylation inhibitors. Molecules. 2022, 27(12): 3834. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform











